Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (471-480 of 768) with videos related to

Pageof 77
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2012
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationPartow Kebriaei, Roland Basset, C Ledesma, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Bone Marrow Transplantation|October 23, 2012
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemiaL M Poon, R Bassett, G Rondon, et al.
Blood|July 5, 2003
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 yearsRaymond Wong, Sergio A Giralt, Thomas Martin, et al.
Leukemia|June 17, 2021
Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationBetül Oran, Richard E Champlin, Feng Wang, et al.
Leukemia|December 8, 2021
Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationBetül Oran, Richard E Champlin, Feng Wang, et al.
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDSBorje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Plos One|January 27, 2012
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsCecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsLenka V Hurton, Harjeet Singh, Amer M Najjar, et al.
Pageof 77

Showing results (471-480 of 768) with videos related to

Sort By:
Pageof 77
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2012
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationPartow Kebriaei, Roland Basset, C Ledesma, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Bone Marrow Transplantation|October 23, 2012
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemiaL M Poon, R Bassett, G Rondon, et al.
Blood|July 5, 2003
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 yearsRaymond Wong, Sergio A Giralt, Thomas Martin, et al.
Leukemia|June 17, 2021
Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationBetül Oran, Richard E Champlin, Feng Wang, et al.
Leukemia|December 8, 2021
Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationBetül Oran, Richard E Champlin, Feng Wang, et al.
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDSBorje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Plos One|January 27, 2012
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsCecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsLenka V Hurton, Harjeet Singh, Amer M Najjar, et al.
Pageof 77